Admin Core
管理核心
基本信息
- 批准号:10614009
- 负责人:
- 金额:$ 13.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccountabilityBindingBioinformaticsCellsClinicalCollaborationsCommunicationCommunitiesContractsDataDrug or chemical Tissue DistributionEnsureEvaluationFosteringFrequenciesGoalsGrantHIVImmune responseIndividualLeadershipMonitorPhenotypePredispositionProductivityProteinsProvirusesQuality ControlRNAResearch PersonnelResource AllocationResourcesSamplingSumTissue-Specific Gene ExpressionVisionWorkcohortdata resourcedata sharingempowermentimmune activationin vivomeetingsmemberorganizational structuresoundsynergism
项目摘要
Project summary/abstract:
The overall scientific goal of this P01 is to understand how the diverse landscape of proviruses and HIV-
expressing cells in vivo differ in their frequency, survival/clearance, relationship to immune responses,
contribution to immune activation, cellular gene expression, tissue specific differences, contribution to rebound,
and susceptibility to therapies aimed at HIV cure. To help implement this scientific goal, an Administrative
Core is needed to serve as a unifying center and provide leadership, management, and organization. Therefore,
we will establish an Administrative Core that will serve and have representatives from all 3 component projects
and the Bioinformatics Core. This Administrative Core will have three main branches corresponding to the three
main aims: Administration, Resource Allocation, and Monitoring. Within the AdministrativeBranch,the Project
Coordinator will organize meetings of each project/core and the entire P01 in order to facilitate scientific
crosstalk and promote the open sharing of ideas. The Resources Branch will have three main subdivisions
(Clinical, Financial, and Data Resources) that will manage the sharing and allocation of clinical samples, financial
resources, and data across all of the projects and cores. The Monitoring Branch will be comprised of an
Executive Committee (composed of the leaders of each project/core) and an external Scientific Advisory
Board (containing independent investigators who are not involved in the P01). These two groups will work
together to track and evaluate progress, ensure accountability, and identify problems and opportunities. With
input from the independent Scientific Advisory Board, the Executive Committee will be empowered to respond
to new challenges or opportunities and reallocate resources in order to implement the overall goals of the P01.
项目总结/摘要:
本P01的总体科学目标是了解前病毒和HIV的多样性是如何-
体内表达细胞在其频率、存活/清除,与免疫应答的关系,
对免疫激活的贡献,细胞基因表达,组织特异性差异,对反弹的贡献,
以及对艾滋病治疗的敏感性。为了帮助实现这一科学目标,
核心需要作为一个统一的中心,并提供领导,管理和组织。因此,我们认为,
我们将建立一个行政核心,该核心将为所有3个组成项目提供服务,并有其代表
和生物信息学核心这个行政核心将有三个主要分支,
主要目标:管理、资源分配和监测。在行政部门内,
协调员将组织每个项目/核心和整个P01的会议,
串话,促进思想的开放共享。资源分支将有三个主要分支
(临床、财务和数据资源),将管理临床样本的共享和分配,财务
资源和数据。监测分支将由
执行委员会(由每个项目/核心的领导人组成)和外部科学顾问
委员会(包含不参与P01的独立研究者)。这两个小组将工作
共同跟踪和评估进展,确保问责制,并确定问题和机会。与
独立的科学咨询委员会的意见,执行委员会将有权作出回应,
应对新的挑战或机遇,重新分配资源,以实现P01的总体目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven A Yukl其他文献
Steven A Yukl的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven A Yukl', 18)}}的其他基金
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
异质性 HIV 表达库:动力学、持久性机制、组织分布和对反弹的贡献
- 批准号:
10459929 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Dynamics, immune responses, and transcriptomics of the HIV-expressing reservoir on ART
ART 上 HIV 表达库的动态、免疫反应和转录组学
- 批准号:
10459932 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
The heterogeneous HIV expressing reservoir: dynamics, persistence mechanisms, tissue distribution, and contribution to rebound
异质性 HIV 表达库:动力学、持久性机制、组织分布和对反弹的贡献
- 批准号:
10614008 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Dynamics, immune responses, and transcriptomics of the HIV-expressing reservoir on ART
ART 上 HIV 表达库的动态、免疫反应和转录组学
- 批准号:
10614015 - 财政年份:2022
- 资助金额:
$ 13.78万 - 项目类别:
Quantification of HIV Reservoirs in the Gut-Associated Lymphatic System
肠道相关淋巴系统中 HIV 储库的定量
- 批准号:
8312343 - 财政年份:2011
- 资助金额:
$ 13.78万 - 项目类别:
Quantification of HIV Reservoirs in the Gut-Associated Lymphatic System
肠道相关淋巴系统中 HIV 储库的定量
- 批准号:
8392982 - 财政年份:2011
- 资助金额:
$ 13.78万 - 项目类别:
Quantification of HIV Reservoirs in the Gut-Associated Lymphatic System
肠道相关淋巴系统中 HIV 储库的定量
- 批准号:
8698381 - 财政年份:2011
- 资助金额:
$ 13.78万 - 项目类别:
Quantification of HIV Reservoirs in the Gut-Associated Lymphatic System
肠道相关淋巴系统中 HIV 储库的定量
- 批准号:
8140703 - 财政年份:2011
- 资助金额:
$ 13.78万 - 项目类别:
Quantification of HIV-1 Reservoirs in the Gut
肠道内 HIV-1 储库的定量
- 批准号:
7929407 - 财政年份:2010
- 资助金额:
$ 13.78万 - 项目类别:
相似国自然基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:32170319
- 批准年份:2021
- 资助金额:58.00 万元
- 项目类别:面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
- 批准号:
- 批准年份:2021
- 资助金额:58 万元
- 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
- 批准号:31672538
- 批准年份:2016
- 资助金额:62.0 万元
- 项目类别:面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
- 批准号:31372080
- 批准年份:2013
- 资助金额:80.0 万元
- 项目类别:面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
- 批准号:81172529
- 批准年份:2011
- 资助金额:58.0 万元
- 项目类别:面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
- 批准号:81070952
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
- 批准号:30672361
- 批准年份:2006
- 资助金额:24.0 万元
- 项目类别:面上项目
相似海外基金
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321481 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
- 批准号:
2321480 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Continuing Grant
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
- 批准号:
DP240103289 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Discovery Projects
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
- 批准号:
EP/Y029542/1 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Fellowship
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
- 批准号:
EP/X039420/1 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Research Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
- 批准号:
2317664 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Standard Grant
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
- 批准号:
2419915 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Standard Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
- 批准号:
2347997 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Discovery Projects
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 13.78万 - 项目类别:
Research Grant